韶能股份(000601.SZ):定增申請獲證監會受理
格隆匯 9 月 10日丨韶能股份(000601.SZ)公佈,2020年9月10日,公司通過中國證監會政務服務平台獲悉:中國證監會已就公司本次非公開發行股票事宜出具《中國證監會行政許可申請受理單》(202420號),中國證監會依法對公司提交的《上市公司非公開發行股票》行政許可申請資料進行了審查,認為該申請材料齊全,符合法定形式,決定對該行政許可申請予以受理。
公司本次非公開發行股票事宜尚需獲得中國證監會核准,能否獲得核准仍存在不確定性。公司將根據中國證監會對該事項的審核進展情況及時履行信息披露義務。敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.